title: Adverse skeletal effects of drugs - beyond Glucocorticoids.
abstract: Osteoporotic fractures are an important public health problem with significant individual and societal costs. In addition to the major risk factors for osteoporotic fracture, low bone mineral density (BMD), age, low body weight and history of fracture or falls, some drugs are now considered to be important secondary risk factor for bone loss and fracture, particularly amongst predisposed individuals. Currently available data are often generated from small observational clinical studies, making risk assessment and development of management guidelines difficult. In many cases, the exposed population has a low baseline risk for fracture and additional assessment and treatment may not be necessary. In this review, we focus on drugs other than glucocorticoids identified as potentially causing adverse skeletal effects, summarizing the existing evidence from preclinical and clinical studies, and suggest recommendations for patient management.
authors.affiliation: Department of Pharmacology, University of Auckland, Auckland, New Zealand.
authors.forename: Susannah
authors.initials: S
authors.lastname: O'Sullivan
authors.forename: Andrew
authors.initials: A
authors.lastname: Grey
mesh_terms: D015519:Bone Density / Q000187:drug effects*; D050723:Fractures, Bone / Q000139:chemically induced*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced*